Hi Buildit - Here are my 2 cents as to why GNBT share price

New Post Public Reply Private Reply Replies (1) Message Board
Paul Jackson Buildit #19133
377
Hi Buildit - Here are my 2 cents as to why GNBT share price is so low, but NGIO's share price can be high -

1. GNBT has issued many shares out - convertible note holders, Veneto/CM...those people own thousands/millions of shares...NGIO spin off is either not happening fast enough for them or they don't believe that would happen easily, so they sell GNBT shares so they can have cash. So far, not too many NGIO shares have been issued...so less possibility of people dumping NGIO shares...

2. It does seem to me some folks want to keep the GNBT PPS low...they can do that on OTC, but will not be able (or will have a hard time) to do that on a major exchange..since NGIO will be spun off to a major exchange, NGIO's PPS should be more in line with its true valuation.

3. GNBT has lots hair on it...some people don't feel comfortable owning GNBT shares...so demand is low....but NGIO does not have any hair on it, demand for those shares will be there especially with vaccine and 10 year efficacy data on breast cancer.

4. Herd mentality - people like to chase stocks that go up...GNBT's PPS has suffered much in the past (bad actors selling when they should not have been selling)...so, GNBT is not a stock of choice right now especially when other stocks are going up daily...why own GNBT when you can't see immediate PPS increase when you can own/trade other hot stocks.

I do think our patience will be paid off eventually...I am hoping by the end of the 2020 at least -

A few things that can propel PPS in the near term
1. BARDA/Health Canada/Malaysia funding
2. China Swine Flu Contract
3. China pays the $1 million and reimburse all covid vaccine development costs
4. GNBT S1s approved
5. NGIO S1s filed
6. Great test results of peptides against infected blood
7. FDA approves - Covid vaccine can start trial 1/2

A couple things that can shoot up PPS in 3-6 months
1. Successful covid vaccine
2. NGIO spins off

Comments/thoughts anyone? Thanks!






Buildit wrote -

Hey, Hoops!

I've sort of run thru a simple analysis of GNBT shares as they relate to NGIO shares a couple of times, and here's my thinking.

1) IF NGIO can get uplisted above $4/sh with 400MM shares (I still don't quite understand why it wasn't 200MM shares, even if we then ended up at $8/sh... but that's a different discussion), that implies a value of $1.6B for NGIO.

2) Let's presume GNBT ends up at 100MM shares OS after paying the bills post-NGIO spin.

3) GNBT keeps 70% of NGIO shares or 280MM shares.

4) This means that each share of GNBT would effectively "own" 2.8 shares of NGIO. That is $11.20 worth of a measurable, liquid asset.

5) So IF the market sees enough value to keep the NGIO shares at or above $4, I fail to see how GNBT shares would remain below $5 and not uplist... unless the market somehow thinks the GNBT assets have a hugely NEGATIVE value.


All that said, I still have a hard time seeing how there is somehow $1.56B ($1.6B less our current GNBT market cap) in value that will be unlocked simply by spinning off NGIO and listing on a major exchange. I've asked the board this Q before. Is simply allowing institutional buyers to participate all it takes to perform that magical release of pent-up value?


Otherwise, someone could come in now and buy GNBT shares to make a killing (as we're all hoping to do).

Currently, if we say GNBT assets are worth $0, the value of a share of NGIO is valued as follows:

1) ~80MM shares of GNBT own ~360MM shares of NGIO (rounding to 90%... I think it's closer to 91%). So each share of GNBT currently "owns" 4.5 shares of NGIO.

2) GNBT share price is $0.52. So $0.52/4.5 = an implied value of $0.1156/sh for NGIO.

3) If you apply a part of the $0.52 to GNBT assets, the implied value of each NGIO share only gets lower.


As I've said before, I think it is a HUGE stretch to fathom how an asset that is currently valued at about a dime is somehow worth $4+ when the uplist happens. And yet here I sit holding... and hoping... which I know is a terrible investment strategy.

Anyone else have insight/wisdom?




Read More: https://investorshangout.com/post/newpost/622...z6TcvOJpz2

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Donatos Targets Texas: Pushing Franchise Growth Limits

Updated Category News Views 6

Donatos Pizza: Ambitious Expansion in the Lone Star State When you think about pizza chains expanding, Donatos Pizza might not be the first name to come to mind, but they're cooking up something big in Texas. Folks in Dallas and Houston better be ready because Donatos is rolling out the red carpet for its edge-to-edge, topping-loaded pies all over Texas. Strategic Growth:...

Continue Reading
Chad Tucker's Sequel Explores Deep Spiritual Themes

Updated Category News Views 6

An Honest Take: Faith, Growth, and Surrender A player in the world of spiritual growth literature has stepped up again, and it ain't holding back. Chad Tucker, a name perhaps familiar to folks following transformation tales soaked with faith, has released a beefy sequel to his first hit: The Lord in Us: If You Can Love an Enemy, You Can Love Anyone. Well, now he's back...

Continue Reading
Airswift's Strategic Acquisition Boosts U.S. Energy Presence

Updated Category News Views 6

What's Driving Airswift's Latest Expansion? Airswift just dropped a bombshell by snapping up key businesses from New Tech Global (NTG), marking a serious power move in the U.S. energy sector. Now, what does this actually mean for investors? In blunt terms: they're muscling up their contractor base by a meaty 30%. That's no small feat. It's a calculated step to ace the...

Continue Reading
Omneky Integrates AI Growth Agent With Slack for Ads

Updated Category News Views 5

Omneky's New Move: AI Growth Agent Meets Slack Picture this: You've got a marketing team hustling in the digital age, and now they've got a new ally. Omneky, the big-wig in autonomous AI growth, has snuck its AI Growth Agent right into Slack. This isn't just a party trick during Dreamforce week in San Francisco. This is Omneky throwing another cog into the advertising...

Continue Reading
Guaranteed Roof Expands with EM Exteriors through LB Capital

Updated Category News Views 5

A Bold Move to Elevate Roofing Standards In a move that seems to jolt the roofing industry awake, Guaranteed Roof is taking the wraps off its new strategic partnership with LB Capital and EM Exteriors. Think of it as a power trio aiming to redefine what roofing solutions should mean in the Southeast. It’s the kind of news that makes you sit up and ask, why now and why...

Continue Reading
Piedmont Orthopedics Expands Care in Henry County

Updated Category News Views 12

A Surgeon's Story Comes to Henry County Ah, the medical field. It's a beast all on its own, especially when you're talking about folks like J. Hunter Matthews, M.D. making waves in the orthopedic world. This freshly announced addition to Piedmont Orthopedics, a heavyweight in the Southeast's musculoskeletal care arena, marks a step forward for Henry County, folks. We're...

Continue Reading
Linkind's Light Stick Revolutionizes Retail Lighting Experience

Updated Category News Views 5

Transforming Lighting in Retail Spaces Folks, let's talk lighting. Not the humdrum switch-you-on kind, but something much snazzier, more customized, and downright interactive. I'm talking about Linkind's latest brainchild—the Smart Light Stick. Launched amidst the neon rush of tm:rw in New York City, this gizmo isn't just another bulb in the home improvement aisle. It's...

Continue Reading
Metriport Eyes Major Step in Health Data Integration

Updated Category News Views 6

Metriport's Push into the TEFCA Framework Son of a gun, Metriport's making noise in the health data world! They just got the nod as a Candidate QHIN under the Trusted Exchange Framework and Common Agreement, or TEFCA if you're into acronyms. This isn't just some digital high-five; it's a significant stride forward for healthcare data exchange. Now they're smack in the...

Continue Reading
Foodcare Proves Effective in Reducing Blood Sugar Levels

Updated Category News Views 6

A New Chapter for Diabetes Care: Foodcare Folks, we've got ourselves a game-changer in the world of diabetes care. Listen closely: Foodsmart's latest study, hot off the press from the American Heart Association's Circulation, essentially hands over the blueprint for tackling type 2 diabetes in an innovative fashion. Now, I'm not the type to get all mushy over scientific...

Continue Reading
Beetles Gel Polish Unveils Vibrant Fall Nail Carnival

Updated Category News Views 6

Beetles Gel Polish Launches Fall Nail Carnival Here comes a new twist on fall fashion, and no, it ain’t your grandma's knitted sweater. We're talking nail polish—a vibrant, flashy ordeal brought to you by Beetles Gel Polish with their Fall Nail Carnival. They're rolling out this spectacle not just for your visions of grandeur nail ideas, but for those seeking deals...

Continue Reading

Top 5 Most Recently Viewed Articles

Celerant Launches Innovative Customer Engagement Platform

Updated Category News Views 127

Celerant Introduces the Customer Engagement Suite Celerant Technology, known for its cutting-edge retail solutions, has launched the Customer Engagement Suite (CES), a transformative platform designed to revolutionize how retailers manage their marketing strategies. A Unified Approach to Retail Marketing With the growing demand for personalized consumer experiences, the...

Continue Reading
Bernstein Changes Stance on Freeport and Antofagasta Stocks

Updated Category News Views 103

Bernstein Adjusts Recommendations for Copper Giants Analysts at Bernstein recently made important adjustments to their recommendations regarding two major players in the copper industry, Freeport McMoRan and Antofagasta. The team downgraded Freeport to a "market-perform" status while upgrading Antofagasta to an "outperform" rating. These decisions arise from a thorough...

Continue Reading
Televerde Foundation's Impact Report Showcases Growth and Success

Updated Category News Views 284

Televerde Foundation Celebrates Key Growth in Impact Report Televerde Foundation, a nonprofit organization dedicated to fostering personal and professional development opportunities for incarcerated women, is proud to unveil its 2024 Impact Report. This report highlights the inspiring journeys of its participants and the foundation's continued success in transforming...

Continue Reading
Conduit Pharmaceuticals Unveils Progress on Autoimmune Pipeline

Updated Category News Views 239

Exciting Developments at Conduit Pharmaceuticals Conduit Pharmaceuticals is making remarkable strides with its pipeline assets, focusing on the innovative treatment of autoimmune diseases. The advancements include preclinical studies for AZD5658, the design of a Phase IIa trial for AZD1656, and formulation optimization aimed at enhancing patient outcomes. Pipeline...

Continue Reading
Hyundai Motor Group's Pleos: Transforming Mobility with Software

Updated Category News Views 306

Hyundai Motor Group Introduces Pleos Software Brand Hyundai Motor Group has launched its new software brand, Pleos, during the Pleos 25 developer conference, presenting a promising vision for the future of mobility. This initiative is part of the company's strategy to enhance its software-centric Cloud Mobility ecosystem. Unveiling New SDV Technologies A key highlight of...

Continue Reading